Harrow, Inc. Interest Income, Other
Harrow, Inc. (HROW) reported Interest Income, Other of $8.68 thousand for the 3-month period ending 2014-06-30, per its 10-Q filed 2014-08-13.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeOther · last filed 2014-08-13
- Harrow, Inc. interest income, other for the quarter ending 2014-06-30 was $8.68K, a 32.92% decline year-over-year.
- Harrow, Inc. interest income, other for the quarter ending 2014-03-31 was $10.31K, a 45.85% increase year-over-year.
- Harrow, Inc. interest income, other for the quarter ending 2013-12-31 was $11.31K, a 101.73% increase year-over-year.
- Harrow, Inc. interest income, other for the quarter ending 2013-09-30 was $12.44K, a 194.72% increase year-over-year.
- Harrow, Inc. interest income, other for fiscal 2013 was $43.76K, a 183.94% increase from fiscal 2012.
- Harrow, Inc. interest income, other for fiscal 2012 was $15.41K.
| Period end | Interest Income, Other 3 month | Interest Income, Other 6 month | Interest Income, Other 9 month | Interest Income, Other 12 month | Interest Income, Other 182 month | Interest Income, Other 185 month | Interest Income, Other 188 month |
|---|---|---|---|---|---|---|---|
| 2014-06-30 | $8.68K 10-Q · filed 2014-08-13 | $18.99K 10-Q · filed 2014-08-13 | $30.30K derived: sum of 3 quarters · filed 2014-08-13 | $42.74K derived: sum of 4 quarters · filed 2014-08-13 | |||
| 2014-03-31 | $10.31K 10-Q · filed 2014-05-15 | $21.62K derived: sum of 2 quarters · filed 2014-05-15 | $34.06K derived: sum of 3 quarters · filed 2014-05-15 | $47.00K derived: sum of 4 quarters · filed 2014-08-13 | $197.06K 10-Q · filed 2014-05-15 | ||
| 2013-12-31 | $11.31K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $23.75K derived: sum of 2 quarters · filed 2014-03-28 | $36.69K derived: sum of 3 quarters · filed 2014-08-13 | $43.76K 10-K · filed 2014-03-28 | $186.75K 10-K · filed 2014-03-28 | ||
| 2013-09-30 | $12.44K 10-Q · filed 2013-11-06 | $25.38K derived: sum of 2 quarters · filed 2014-08-13 | $32.45K 10-Q · filed 2013-11-06 | $38.05K derived: sum of 4 quarters · filed 2014-08-13 | $175.44K 10-Q · filed 2013-11-06 | ||
| 2013-06-30 | $12.94K 10-Q · filed 2014-08-13 | $20.01K 10-Q · filed 2014-08-13 | $25.61K derived: sum of 3 quarters · filed 2014-08-13 | $29.83K derived: sum of 4 quarters · filed 2014-08-13 | |||
| 2013-03-31 | $7.07K 10-Q · filed 2014-05-15 | $12.67K derived: sum of 2 quarters · filed 2014-05-15 | $16.89K derived: sum of 3 quarters · filed 2014-05-15 | ||||
| 2012-12-31 | $5.61K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $9.83K derived: sum of 2 quarters · filed 2014-03-28 | $15.41K 10-K · filed 2014-03-28 | ||||
| 2012-09-30 | $4.22K 10-Q · filed 2013-11-06 | $9.80K 10-Q · filed 2013-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |